LianBio (LIAN)
NASDAQ: LIAN
· Real-Time Price · USD
0.32
0.00 (0.31%)
At close: Jan 16, 2025, 10:00 PM
LianBio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 300.02K | 296.78K | 323.37K | 316.48K | 297.77K | 199.01K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -300.02K | -296.78K | -323.37K | -316.48K | -297.77K | -199.01K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -26.3M | -25.04M | -25.97M | -29.25M | -24.55M | -43.14M | -28.42M | -22.04M | -13.54M | -99.49M | -60.5M |
Interest Income | 2.71M | 2.75M | 2.41M | 957.00 | 1.41M | 553K | 280K | 72.14K | 32K | 106K | 33K |
Pretax Income | -23.45M | -21.42M | -23.61M | -18.63M | -21.89M | -42.39M | -27.72M | -22.23M | -13.51M | -99.45M | -60.59M |
Net Income | -24.04M | -21.62M | -24.05M | -18.28M | -21.9M | -42.39M | -27.73M | -21.2M | -13.11M | -100.43M | -61.56M |
Selling & General & Admin | 17.28M | 15.59M | 15.14M | 18.67M | 16.29M | 14.55M | 16.09M | 14.38M | 8.89M | 6.46M | 7.15M |
Research & Development | 9.02M | 9.45M | 10.83M | 10.58M | 8.26M | 28.59M | 12.33M | 7.65M | 4.66M | 93.03M | 53.35M |
Other Expenses | n/a | 869K | -44K | 8.54M | 1.25M | 203K | 417K | -265K | 3K | -68K | -124K |
Operating Expenses | 26.3M | 25.04M | 25.97M | 29.25M | 24.55M | 43.14M | 28.42M | 22.04M | 13.54M | 99.49M | 60.5M |
Interest Expense | n/a | n/a | n/a | n/a | 1.41M | 553K | n/a | 243K | 32K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 26.3M | 25.04M | 25.97M | 29.25M | 24.55M | 43.14M | 28.42M | 22.04M | 13.54M | 99.49M | 60.5M |
Income Tax Expense | 586K | 200K | 438K | -350K | 6K | 5K | 6K | -1.03M | -397K | 975K | 975K |
Shares Outstanding (Basic) | 107.17M | 107.16M | 107.16M | 108.13M | 108.35M | 107.92M | 107.28M | 75.48M | 105.26M | 105.26M | 105.26M |
Shares Outstanding (Diluted) | 107.17M | 107.16M | 107.16M | 108.13M | 108.35M | 107.92M | 107.28M | 75.48M | 105.26M | 105.26M | 105.26M |
EPS (Basic) | -0.22 | -0.2 | -0.22 | -0.17 | -0.2 | -0.39 | -0.26 | -0.28 | -0.12 | -0.95 | -0.58 |
EPS (Diluted) | -0.22 | -0.2 | -0.22 | -0.17 | -0.2 | -0.39 | -0.26 | -0.28 | -0.12 | -0.95 | -0.58 |
EBITDA | -25.98M | -24.71M | -25.64M | -28.93M | -24.27M | -43M | -28.15M | -21.79M | -13.4M | -99.42M | -60.43M |
EBIT | -26.3M | -25.04M | -25.97M | -29.25M | -24.55M | -43.14M | -28.42M | -22.04M | -13.54M | -99.49M | -60.5M |
Depreciation & Amortization | 325K | 334K | 324K | 317K | 280K | 138K | 271K | 247K | 141K | 71K | 66K |